Adastra Holdings Ltd.

XTXXF Biotech & pharma

Develops cannabis extracts for medical cannabis patients.

Dec 2022Revenue C$13.3M/yrExpenses C$14.1M/yr
No trend
Figures by year

When will Adastra Holdings be profitable?

Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2022, revenue was C$13.3M and expenses C$14.1M.

Fiscal year toRevenueExpensesOperating profit
Dec 2022C$13.3MC$14.1M−C$800K
Dec 2021C$5.63MC$8.02M−C$2.39M
Dec 2020C$2.50MC$9.66M−C$7.17M